|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 434.71 USD | +1.14% |
|
+1.28% | -3.97% |
| 05-06 | Vertex Pharmaceuticals Incorporated Signs Reimbursement Agreement for Casgevy in Germany | CI |
| 05-05 | Vertex Pharmaceuticals Insider Sold Shares Worth $469,222, According to a Recent SEC Filing | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.14% | +1.28% | -1.07% | -5.61% | -3.97% | -0.91% | +24.25% | +104.39% | +420.58% | 109B | |
| +1.86% | -0.13% | +3.99% | -4.78% | -10.05% | +27.94% | +121.94% | +396.36% | +1,166.77% | 846B | |
| -0.26% | -1.34% | -7.05% | -8.17% | +6.88% | +43.50% | +37.39% | +30.97% | +93.40% | 533B | |
| +0.58% | -2.37% | -1.57% | -8.00% | -11.06% | +6.92% | +38.63% | +76.88% | +224.11% | 356B | |
| +1.21% | -0.97% | -0.10% | -10.20% | -3.93% | +22.40% | +12.53% | +4.49% | +29.12% | 324B | |
| +1.18% | +1.29% | -9.91% | -8.88% | -2.09% | +31.44% | +13.23% | +76.91% | +243.34% | 282B | |
| +0.30% | -0.12% | -5.74% | -7.64% | +3.74% | +24.02% | +22.81% | +44.07% | +55.22% | 278B | |
| +0.44% | -0.83% | -6.64% | -5.98% | +6.56% | +39.46% | -4.58% | +44.81% | +106.54% | 275B | |
| +3.34% | +6.03% | +25.92% | -2.18% | -7.76% | -32.03% | -48.08% | +28.96% | +67.41% | 203B | |
| -1.04% | +1.51% | -6.03% | -10.32% | +0.44% | +19.64% | +41.52% | +30.30% | +113.22% | 179B | |
| +1.36% | +0.76% | -3.84% | -14.19% | +8.93% | +28.78% | +69.88% | +98.89% | +59.35% | 163B | |
| +0.06% | -2.26% | -5.98% | -7.30% | +3.23% | +11.33% | -31.60% | -34.68% | -22.48% | 146B | |
| -1.20% | -3.19% | -4.32% | -7.31% | +2.98% | +15.30% | -19.59% | -13.55% | -21.55% | 115B | |
| +0.16% | -5.90% | -7.79% | -11.31% | -11.48% | -19.66% | -26.16% | -14.01% | +5.37% | 103B | |
| +0.08% | -0.67% | -15.00% | -14.21% | +1.10% | +31.80% | +27.66% | +10.93% | +0.04% | 100B | |
| +0.67% | -3.54% | -8.32% | -11.85% | -3.52% | -3.24% | +122.28% | +90.67% | +548.34% | 83.01B | |
| -0.98% | -1.47% | -9.94% | -7.51% | +6.76% | +21.92% | +12.83% | +38.39% | -2.40% | 52.58B | |
| +1.36% | -0.67% | -6.20% | -8.36% | -10.16% | +1.34% | +15.47% | -20.05% | +273.76% | 51.53B | |
| +0.27% | -0.86% | -9.10% | -19.61% | +0.19% | +54.11% | -31.26% | -30.60% | -62.92% | 42.76B | |
| +1.27% | +2.45% | +16.26% | +5.55% | +16.04% | +101.64% | +341.11% | +253.32% | -28.88% | 41.6B | |
| Average | +0.64% | -1.42% | -3.12% | -8.39% | -0.36% | +21.28% | +37.01% | +60.87% | +163.42% | 214.18B | |
| Weighted average by Cap. | +0.85% | -1.42% | -2.03% | -7.69% | -1.94% | +22.55% | +41.81% | +111.22% | +321.93% |
- Stock Market
- Equities
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition